This item is authorised by the following title:
National Health (Highly Specialised Drugs Program) Special Arrangement Amendment (Medication Charts for Complex Authority Required (CAR) and rituximab Pharmaceutical Benefits) Instrument 2026 (PB 14 of 2026 | F2026L00043)
National Health (Highly Specialised Drugs Program) Special Arrangement Amendment (Increases in Maximum Quantity and Number of Repeats for Complex Authority Required (CAR) Medicines) Instrument 2026 (PB 15 of 2026 | F2026L00045)
National Health (Highly Specialised Drugs Program) Special Arrangement Amendment (February Update) Instrument 2026 (PB 6 of 2026 | F2026L00068)
National Health (Highly Specialised Drugs Program) Special Arrangement Amendment (January Update) Instrument 2025 (PB 157 of 2025 | F2025L01663)
National Health (Highly Specialised Drugs Program) Special Arrangement Amendment (December Update) Instrument 2025 (PB 138 of 2025 | F2025L01456)
National Health (Highly Specialised Drugs Program) Special Arrangement Amendment (November Update) Instrument 2025 (PB 126 of 2025 | F2025L01318)
National Health (Highly Specialised Drugs Program) Special Arrangement Amendment (October Update) Instrument 2025 (PB 109 of 2025 | F2025L01215)
National Health (Highly Specialised Drugs Program) Special Arrangement Amendment (September Update) Instrument 2025 (PB 97 of 2025 | F2025L01022)
National Health (Highly Specialised Drugs Program) Special Arrangement Amendment (August Update) Instrument 2025 (PB 88 of 2025 | F2025L00881)
National Health (Highly Specialised Drugs Program) Special Arrangement Amendment (July Update) Instrument 2025 (PB 77 of 2025 | F2025L00783)
National Health (Highly Specialised Drugs Program) Special Arrangement Amendment (June Update) Instrument 2025 (PB 58 of 2025 | F2025L00625)
National Health (Highly Specialised Drugs Program) Special Arrangement Amendment (May Update) Instrument 2025 (PB 44 of 2025 | F2025L00538)
View Explanatory Statement/s
